z-logo
open-access-imgOpen Access
An end-to-end assessment on the accuracy of adaptive radiotherapy in an MR-linac
Author(s) -
A T Axford,
Νικόλαος Δικαίος,
David Roberts,
Catharine Clark,
Philip Evans
Publication year - 2021
Publication title -
physics in medicine and biology/physics in medicine and biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.312
H-Index - 191
eISSN - 1361-6560
pISSN - 0031-9155
DOI - 10.1088/1361-6560/abe053
Subject(s) - imaging phantom , dosimetry , nuclear medicine , radiation treatment planning , radiation therapy , consistency (knowledge bases) , scanner , computer science , medical physics , medicine , radiology , artificial intelligence
Purpose. To develop and demonstrate an end-to-end assessment procedure for adaptive radiotherapy (ART) within an MR-guided system. Methods and materials. A 3D printed pelvic phantom was designed and constructed for use in this study. The phantom was put through the complete radiotherapy treatment chain, with planned internal changes made to model prostate translations and shape changes, allowing an investigation into three ART techniques commonly used. Absolute dosimetry measurements were made within the phantom using both gafchromic film and alanine. Comparisons between treatment planning system (TPS) calculations and measured dose values were made using the gamma evaluation with criteria of 3 mm/3% and 2 mm/2%. Results. Gamma analysis evaluations for each type of treatment plan adaptation investigated showed a very high agreement with pass rates for each experiment ranging from 98.10% to 99.70% and 92.60% to 97.55%, for criteria of 3%/3 mm and 2%/2 mm respectively. These pass rates were consistent for both shape and position changes. Alanine measurements further supported the results, showing an average difference of 1.98% from the TPS. Conclusion. The end-to-end assessment procedure provided demanding challenges for treatment plan adaptations to demonstrate the capabilities and achieved high consistency in all findings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here